Fred B. Oldham
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Hematology 10
- Hematopoietic Stem Cell Transplantation 8
- Acute Myeloid Leukemia Research 1
- Oncology 12
- Cancer Treatment and Pharmacology 4
- Cancer Cells and Metastasis 3
- Neutropenia and Cancer Infections 3
- Co-authors
- Jack W. Singer (8 shared papers)David F. Stroncek (2 shared papers)Mary Ellen Clay (2 shared papers)Jeffrey McCullough (2 shared papers)Gabriella Pezzoni (1 shared paper)Stewart D. Chipman (1 shared paper)Waclaw B. Jaszcz (1 shared paper)Martin Petzoldt (1 shared paper)
- Journals
- Journal of Thoracic Oncology (5 papers)Blood (2 papers)Journal of Clinical Oncology (2 papers)British Journal of Cancer (2 papers)Transfusion (2 papers)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Fred B. Oldham
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 77
- Hematology 410
- Biomaterials 264
- Oncology 372
- Genetics 135
- Immunology 137
Countries citing papers authored by Fred B. Oldham
This map shows the geographic impact of Fred B. Oldham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred B. Oldham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred B. Oldham more than expected).
Fields of papers citing papers by Fred B. Oldham
This network shows the impact of papers produced by Fred B. Oldham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred B. Oldham. The network helps show where Fred B. Oldham may publish in the future.
Co-authors
The 25 scholars most cited alongside Fred B. Oldham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 197 | |
| 2 | 1996 | 167 | |
| 3 | 2008 | 143 | |
| 4 | 1996 | 122 | |
| 5 | 2006 | 116 | |
| 6 | 2008 | 108 | |
| 7 | 1992 | 52 | |
| 8 | 1996 | 44 | |
| 9 | 1999 | 40 | |
| 10 | 2005 | 37 | |
| 11 | 2008 | 34 | |
| 12 | 2005 | 24 | |
| 13 | 1998 | 21 | |
| 14 | Phase I-II trial of high-dose epirubicin in patients with lymphoma. | 1987 | 20 |
| 15 | 1998 | 17 | |
| 16 | Phase I-II study of epirubicin in multiple myeloma. | 1988 | 14 |
| 17 | 1990 | 12 | |
| 18 | 1996 | 10 | |
| 19 | Mobilization and purification of CD34+ cells from normal donors-regimens with G-CSF, GM-CSF, or a combination of both. | 1996 | 7 |
| 20 | 1995 | 6 |
About Fred B. Oldham
Fred B. Oldham is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers), Neutropenia and Cancer Infections (3 papers), Lung Cancer Treatments and Mutations (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hematology (410 citations), Biomaterials (264 citations), Oncology (372 citations), Genetics (135 citations) and Immunology (137 citations). Fred B. Oldham has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Jack W. Singer, David F. Stroncek, Mary Ellen Clay, Jeffrey McCullough, Gabriella Pezzoni, Stewart D. Chipman, Waclaw B. Jaszcz, Martin Petzoldt, Jesse Joshua Smith and Amy J. Eisenfeld. Their work appears in journals such as Journal of Thoracic Oncology, Blood, Journal of Clinical Oncology, British Journal of Cancer and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.